Mode
Text Size
Log in / Sign up
N/A N=103 Single-blind Treatment

Evaluation of the Ulthera™ System for Obtaining Lift and Tightening of the Cheek Tissue

Mild to Moderate Skin Laxity on Cheek · Mild to Moderate Skin Laxity on Upper Neck · Mild to Moderate Subcutaneous Fat on Cheek · Mild to Moderate Subcutaneous Fat on Upper Neck

Enrolled (actual)
103
Serious AEs
0.0%
Results posted
Aug 2013
Primary outcome: Primary: Change in Overall Lifting and Tightening of Treated Tissue on the Lower Face and Submental Regions. — 68.60 percentage of participants improved

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Ulthera treatment (Device)
Age
Adult · 35+ yrs
Sex
All
Sponsor
Ulthera, Inc
Primary completion
Dec 2010

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Overall Lifting and Tightening of Treated Tissue on the Lower Face and Submental Regions.
68.60
SECONDARY
Change in Submental and Neck Skin Laxity by Quantitative Analysis
72.9
SECONDARY
Patient Satisfaction Questionnaire
67

Summary

The clinical trial evaluates the clinical outcomes associated with the non-invasive treatment to obtain lift and tightening of the cheek tissue and improve jawline definition and submental skin laxity utilizing the Ulthera™ System which delivers ultrasound energy in a focused manner below the surface of the skin

Eligibility Criteria

Inclusion Criteria

  • Male or female, aged 35 to 60 years
  • Subject in good health
  • Desire lift and tightening of cheek tissue, improvement of jawline definition or submental skin laxity

Exclusion Criteria

  • Pregnant or lactating
  • Has an active systemic or local skin disease that may alter wound healing
  • Severe solar elastosis
  • Excessive subcutaneous fat on the cheeks
  • Excessive skin laxity on the lower face and neck
  • Has significant scarring in areas to be treated
  • Has significant open facial wounds or lesions
  • Has severe or cystic acne on the face
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01368835). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search